BGLC
BioNexus Gene Lab·NASDAQ
--
--(--)
--
--(--)
2.05 / 10
Underperform
Technical assessment is poor, scoring 2.05/10. Both identified patterns—Marubozu White and Long Upper Shadow—signal bearish pressure, with no bullish cues. Recent five‑day data show dominant negative signals, indicating heightened downside risk.
Analysis Checks(0/2)
Long Upper Shadow
Score1/10
Win Rate38.03%
Hist. Signals71
Avg Return-1.25%
Score1/10
Win Rate38.03%
Hist. Signals71
Avg Return-1.25%
Marubozu White
Score3.11/10
Win Rate47.50%
Hist. Signals40
Avg Return0.97%
Score3.11/10
Win Rate47.50%
Hist. Signals40
Avg Return0.97%
Long Upper Shadow
Score1/10
Win Rate38.03%
Hist. Signals71
Avg Return-1.25%
Score1/10
Win Rate38.03%
Hist. Signals71
Avg Return-1.25%
Marubozu White
Score3.11/10
Win Rate47.50%
Hist. Signals40
Avg Return0.97%
Score3.11/10
Win Rate47.50%
Hist. Signals40
Avg Return0.97%
What is the current technical signals for BGLC?
- BGLC presents a Underperform setup with a Technical Score of 2.05/10. Key technical indicators highlight an RSI of 0.00 and a MACD of 0.00, with the trend anchored by the 50-Day SMA at 0.00.
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
